Mesoblastic nephroma differential diagnosis: Difference between revisions
Jump to navigation
Jump to search
Shanshan Cen (talk | contribs) (Created page with "__NOTOC__ {{Mesoblastic nephroma}} {{CMG}}; {{AE}} {{SC}} ==Overview== ==References== {{reflist|2}} {{WH}} {{WS}} Category:Disease Category:Types of cancer") |
Shanshan Cen (talk | contribs) No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{SC}} | {{CMG}}; {{AE}} {{SC}} | ||
==Overview== | ==Overview== | ||
== Differential diagnosis == | |||
A common differential diagnosis includes the following tumors: | |||
* Mesoblastic nephroma (congenital): from birth to 1 year | |||
* [[Rhabdoid tumor]]: from 1 to 2 years of age | |||
* [[Clear cell sarcoma of the kidney]]: from 2 to 3 years of age. | |||
* [[Wilm's tumor]]: over 3 years of age. | |||
The age breakdown is far from exact, but provides a useful age range and approximate order. Wilm's is most common, accounting for 80-85% of all pediatric kidney tumors. Congenital mesoblastic nephroma accounts for about 10-15%; rhabdoid and CCSK split the remained 5-10%. | |||
==References== | ==References== | ||
Revision as of 20:06, 2 November 2015
|
Mesoblastic nephroma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Mesoblastic nephroma differential diagnosis On the Web |
|
American Roentgen Ray Society Images of Mesoblastic nephroma differential diagnosis |
|
Risk calculators and risk factors for Mesoblastic nephroma differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shanshan Cen, M.D. [2]
Overview
Differential diagnosis
A common differential diagnosis includes the following tumors:
- Mesoblastic nephroma (congenital): from birth to 1 year
- Rhabdoid tumor: from 1 to 2 years of age
- Clear cell sarcoma of the kidney: from 2 to 3 years of age.
- Wilm's tumor: over 3 years of age.
The age breakdown is far from exact, but provides a useful age range and approximate order. Wilm's is most common, accounting for 80-85% of all pediatric kidney tumors. Congenital mesoblastic nephroma accounts for about 10-15%; rhabdoid and CCSK split the remained 5-10%.